Potential risks include nausea, vomiting, diarrhea, constipation, abdominal discomfort, and in rare cases, pancreatitis or gallbladder issues
Individuals with CKD and diabetes often have additional medical conditions that increase their risk for hyperkalemia
Conclusion These findings highlight the potential of DPI as an effective alternative to injectable and oral semaglutide and offer a promising approach for improved semaglutide delivery
Sustainable lifestyle changes, medical support, and, in some cases, weight loss medications can all play a role in a successful fertility journey
Documented side effects or contraindications from previous weight loss medications can override these requirements, but proving medical necessity requires thorough documentation